DE3587698D1 - Pharmazeutische Präparate. - Google Patents

Pharmazeutische Präparate.

Info

Publication number
DE3587698D1
DE3587698D1 DE88119741T DE3587698T DE3587698D1 DE 3587698 D1 DE3587698 D1 DE 3587698D1 DE 88119741 T DE88119741 T DE 88119741T DE 3587698 T DE3587698 T DE 3587698T DE 3587698 D1 DE3587698 D1 DE 3587698D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparations
active agent
reservoir
pharmaceutical composition
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88119741T
Other languages
English (en)
Other versions
DE3587698T2 (de
Inventor
Thomas Kissel
Henriette Schrank
Hans-Rainer Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Ag Basel Ch Lts Lohmann Therapie-System
Original Assignee
Sandoz AG
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, LTS Lohmann Therapie Systeme AG filed Critical Sandoz AG
Application granted granted Critical
Publication of DE3587698D1 publication Critical patent/DE3587698D1/de
Publication of DE3587698T2 publication Critical patent/DE3587698T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE88119741T 1984-03-01 1985-02-22 Pharmazeutische Präparate. Expired - Lifetime DE3587698T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH100884 1984-03-01
CH175384 1984-04-06

Publications (2)

Publication Number Publication Date
DE3587698D1 true DE3587698D1 (de) 1994-02-03
DE3587698T2 DE3587698T2 (de) 1994-04-28

Family

ID=25686369

Family Applications (4)

Application Number Title Priority Date Filing Date
DE3587794T Expired - Lifetime DE3587794T2 (de) 1984-03-01 1985-02-22 Pharmazeutische Präparate.
DE8888119742T Expired - Lifetime DE3587048T2 (de) 1984-03-01 1985-02-22 Pharmazeutische praeparate.
DE85810072T Expired - Lifetime DE3587358T2 (de) 1984-03-01 1985-02-22 Pharmazeutische zusammensetzungen.
DE88119741T Expired - Lifetime DE3587698T2 (de) 1984-03-01 1985-02-22 Pharmazeutische Präparate.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DE3587794T Expired - Lifetime DE3587794T2 (de) 1984-03-01 1985-02-22 Pharmazeutische Präparate.
DE8888119742T Expired - Lifetime DE3587048T2 (de) 1984-03-01 1985-02-22 Pharmazeutische praeparate.
DE85810072T Expired - Lifetime DE3587358T2 (de) 1984-03-01 1985-02-22 Pharmazeutische zusammensetzungen.

Country Status (18)

Country Link
EP (3) EP0315218B1 (de)
JP (2) JPH0667835B2 (de)
KR (1) KR920010392B1 (de)
AT (3) ATE89750T1 (de)
AU (2) AU578275B2 (de)
CA (1) CA1257837A (de)
DE (4) DE3587794T2 (de)
DK (2) DK175774B1 (de)
GR (1) GR850507B (de)
HK (2) HK157896A (de)
HU (1) HU197847B (de)
IE (2) IE81316B1 (de)
IL (1) IL74446A (de)
MY (1) MY101919A (de)
NZ (1) NZ211248A (de)
PH (1) PH24392A (de)
PT (1) PT80033B (de)
WO (1) WO1985003878A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
DE3643987A1 (de) * 1986-12-22 1988-06-23 Lohmann Therapie Syst Lts Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
WO1996024377A1 (de) * 1995-02-10 1996-08-15 Christian Noe Partikuläre arzneiform
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
JP4575632B2 (ja) * 1999-12-14 2010-11-04 帝國製薬株式会社 片頭痛緩和用薬剤
DE10011447A1 (de) * 2000-03-10 2001-09-20 Roehm Gmbh Dispersion mit nichtionischem Emulgator
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
KR101725832B1 (ko) * 2009-05-01 2017-04-11 히사미쓰 세이야꾸 가부시키가이샤 경피 흡수형 제제
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
WO2018199018A1 (ja) * 2017-04-26 2018-11-01 ニプロ株式会社 経皮吸収型製剤およびその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH653256A5 (en) * 1981-04-06 1985-12-31 Sandoz Ag Microemulsion for cutaneous use
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
ATE20311T1 (de) * 1981-07-08 1986-06-15 Key Pharma Polymerische diffusionsmatritze propranolol enthaltend.
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS5925320A (ja) * 1982-08-02 1984-02-09 Watanabe Yakuhin Kogyo Kk 薬物投与用貼付剤
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating

Also Published As

Publication number Publication date
JPH0667835B2 (ja) 1994-08-31
AU607496B2 (en) 1991-03-07
ATE89750T1 (de) 1993-06-15
PT80033A (en) 1985-03-01
JP2540019B2 (ja) 1996-10-02
ATE98876T1 (de) 1994-01-15
EP0315219A3 (de) 1991-03-06
DK324687D0 (da) 1987-06-25
DE3587358D1 (de) 1993-07-01
IE81316B1 (en) 2000-09-20
MY101919A (en) 1992-02-15
IL74446A0 (en) 1985-05-31
IE850493L (en) 1985-09-01
IL74446A (en) 1990-11-29
DK164257B (da) 1992-06-01
PH24392A (en) 1990-06-13
IE940083L (en) 1985-09-01
DE3587048D1 (de) 1993-03-11
AU1662688A (en) 1988-10-20
DE3587048T2 (de) 1993-06-03
KR850700218A (ko) 1985-12-26
EP0315218A2 (de) 1989-05-10
DK164257C (da) 1992-10-19
HK157896A (en) 1996-08-30
EP0315218B1 (de) 1993-12-22
DE3587794D1 (de) 1994-05-11
HU197847B (en) 1989-06-28
DE3587358T2 (de) 1993-11-04
EP0155229A3 (en) 1985-12-11
DE3587794T2 (de) 1994-08-04
GR850507B (de) 1985-06-28
JPS61501324A (ja) 1986-07-03
DK324687A (da) 1987-06-25
PT80033B (pt) 1987-10-20
EP0315218A3 (de) 1991-03-06
AU578275B2 (en) 1988-10-20
HK220096A (en) 1997-01-03
NZ211248A (en) 1988-10-28
ATE103819T1 (de) 1994-04-15
DK502985D0 (da) 1985-10-31
JPH0748253A (ja) 1995-02-21
AU4065085A (en) 1985-09-24
WO1985003878A1 (en) 1985-09-12
DK502985A (da) 1985-10-31
DK175774B1 (da) 2005-02-14
EP0315219B1 (de) 1993-01-27
KR920010392B1 (ko) 1992-11-27
EP0155229B1 (de) 1993-05-26
DE3587698T2 (de) 1994-04-28
CA1257837A (en) 1989-07-25
IE61754B1 (en) 1994-11-30
HUT41644A (en) 1987-05-28
EP0315219A2 (de) 1989-05-10
EP0155229A2 (de) 1985-09-18

Similar Documents

Publication Publication Date Title
DE3587048T2 (de) Pharmazeutische praeparate.
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
ES2032303T3 (es) Soluciones nasales.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
ES2043719T3 (es) Administracion de farmacos por via percutanea.
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
ATE84975T1 (de) Pharmazeutische praeparate.
IL89251A (en) Pharmaceutical compositions for the systemic transdermal administration of pharmacologically active agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH LTS LOHMANN THERAPIE-SYSTEM